This article was originally published in The Gray Sheet
Executive SummaryPrivately held distributor of specialty medical products envisions an initial public offering after revenues increase to $250 mil., the firm states in a Dec. 14 release. With current projected sales of $115 mil., the firm has expanded its geographic coverage to the West Coast by acquiring Redmond, Washington-based specialty distributor Omnimedical. "The acquisition gives HTD a presence in 30 states with coverage of 67% of the U.S. population," the company says. HTD was formed in May 1998 through the merger of four medical specialty distributors including Triad Medical, Bimeco, Futuretech and MegaTech Medical
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.